Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Mar 7;12(3):e8579.
doi: 10.1002/ccr3.8579. eCollection 2024 Mar.

Mixed treatment for same-severe mixed urinary incontinence: A novel method

Daryoush Hamidi Alamdari  1 , Armina Douzandeh  2 , Maliheh Keshvari Shirvan  3 , Behzad Narouie  4 , Negar Radpour  5
Affiliations
Case Reports

Mixed treatment for same-severe mixed urinary incontinence: A novel method

Daryoush Hamidi Alamdari et al. Clin Case Rep. .

Abstract

Key clinical message: Innovative mixed treatment offers hope for persistent mixed urinary incontinence (MUI): PRP-Fibrin Glue-Stem Cell injection, Botox, and TVT in a single session. Successful case study reveals promising outcomes, emphasizing the need for further research.

Abstract: Mixed urinary incontinence is a complaint of stress and urge incontinence which affects patients' quality of life and dramatic changes in patients' physical, mental, and socioeconomic status. The treatment is challenging and depends on the dominance of one of the complaints to the other. The progress in the method of treatment is still under discussion. This study reports treatment of a MUI case in a 56-year-old, with a history of MUI of 7-year duration, which was persistent to pharmacological treatment, pelvic muscle training, biofeedback, and anti-incontinence surgery (Burch Colposuspension). PRP-Fibrin Glue-Stem Cell injection, Botox injection, and TVT were performed in a one surgery session. Patient was discharged with ability to urinate with acceptable amount of post void residue. After 3-month follow-up, patient was completely satisfied and happy. Further research is needed to substantiate the efficacy of these mixed treatments for MUI.

Keywords: novel treatment; platelet‐rich plasma; stem cells; treatment efficacy; urinary incontinence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest regarding the publication of this article.All human subjects provided written informed consent with guarantees of confidentiality. The authors are employed at an academic or research institution where research or education is the primary function of the entity.

Similar articles

See all similar articles

References

    1. Haylen BT, De Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4‐20. - PubMed
    1. McDougal WS, Wein AJ, Kavoussi LR, Partin AW, Peters CA. Campbell‐Walsh Urology. 11th ed. Review E‐Book. Elsevier Health Sciences; 2015.
    1. Shirvan MK, Alamdar DH, Ghorifi A, Rahimi HR. A novel treatment for urethrovaginal fistula: autologous platelet‐rich–plasma injection and platelet‐rich–fibrin‐glue interposition. J Gynecol Surg. 2013;29(5):268‐270.
    1. Gomelsky A, Dmochowski RR. Treatment of mixed urinary incontinence. Cent Eur J Urol. 2011;64(3):120‐126. - PMC - PubMed
    1. Committee on Practice Bulletins‐Gynecology, American Urogynecologic Society . ACOG practice bulletin no. 155 summary: urinary incontinence in women. Obstet Gynecol. 2015;126(5):1120‐1122. - PubMed

Publication types